Cargando…
Target/therapies for chronic recurrent erythema nodosum leprosum
A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and...
Autores principales: | Thangaraju, Pugazhenthan, Varthya, Shoban Babu, Venkatesan, Sajitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446680/ https://www.ncbi.nlm.nih.gov/pubmed/32874007 http://dx.doi.org/10.4103/ijp.IJP_788_19 |
Ejemplares similares
-
Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020) -
Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019) -
Named terminologies of patient-centered – A focus respective to stigmatized disease
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020) -
Curcumin and fungal infection – commonly available herbs for common female infection
por: Varthya, Shoban Babu, et al.
Publicado: (2020) -
Low-dose oxytocin - a safe strategy in postpartum hemorrhage
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)